UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
LG Chem working on antidiabetic Zemiglo combo
LG Chem is likely to develop an antidiabetic drug that combines DPP-4 (dipe...
by Lee Hye-seon
|
2018-01-26 12:25
라인
Ildong to market Novartis’ shingles treatment
Ildong Pharmaceuticals said Thursday that it has signed a sales agreement w...
by Lee Han-soo
|
2018-01-25 16:15
라인
Patent expirations to open way for generic drugs in 2018
As well-selling original drugs, including Gilead’s hepatitis B treatment Vi...
by So Jae-hyeon
|
2018-01-25 15:38
라인
Pharmbio Korea launches autoimmune disease treatment
Pharmbio Korea said Thursday that it has launched Azabio (Ingredient: Azath...
by Lee Han-soo
|
2018-01-25 15:27
라인
GC Wellbeing to help healthcare startups
GC Wellbeing, a subsidiary of GC Pharma, said Thursday that it has signed a...
by Lee Han-soo
|
2018-01-25 12:54
라인
Handok to market Lilly Korea’s erectile dysfunction treatment
Handok said Thursday that it has signed a strategic partnership agreement w...
by Lee Han-soo
|
2018-01-25 11:11
라인
FDA report cites problems at Daewoong's Botox plant
The U.S. Food and Drug Administration (FDA) said it has pointed out 10 prob...
by Lee Han-soo
|
2018-01-25 10:19
라인
Dong-A ST, ABL Bio agree on immunotherapeutic dual antibody anti-cancer drug
Dong-A ST said Tuesday that it has signed an agreement with ABL Bio, a dome...
by Lee Han-soo
|
2018-01-24 18:15
라인
Novo Nordisk Korea says Saxenda leads sales in global obesity market
Novo Nordisk Korea said Wednesday that its obesity therapy Saxenda (liraglu...
by Marian Chu
|
2018-01-24 16:55
라인
Pharma industry group elects new head
The Korea Research-based Pharma Industry Association (KRPIA) has elected Av...
by Lee Han-soo
|
2018-01-24 15:41
라인
Dong-A ST holds news conference to promotes its weight loss drug
Dong-A ST said Contrave, the company’s weight loss pill, has sharply enhanc...
by Lee Han-soo
|
2018-01-24 15:15
라인
Contrast medium market shrank last year
Sales of contrast medium products went down in the domestic market last yea...
by Nam Doo-hyun
|
2018-01-24 15:14
라인
Eli Lilly to test atopic dermatitis treatment in Korea
Eli Lilly plans to conduct a phase-3 clinical trial on baricitinib (under t...
by Lee Hye-seon
|
2018-01-24 11:24
라인
MSD slows down in hyperlipidemia combos market
MSD’s performance is slowing down in the local market of ezetimibe-active c...
by So Jae-hyeon
|
2018-01-23 16:03
라인
GC launches locally-developed TD vaccine for adults
GC Pharma, formerly known as Green Cross, said that it has officially launc...
by Lee Han-soo
|
2018-01-23 10:43
라인
Sillajen, ABL agree to develop virus manufacturing process
Sillajen said Monday that it has signed an agreement with ABL Europe, a glo...
by Lee Han-soo
|
2018-01-22 16:30
라인
Drugs topping sales of W10 billion rise in number
Corezetta, a company specializing in healthcare big data, said Monday that ...
by Lee Han-soo
|
2018-01-22 15:14
라인
Hanmi, Chong Kun Dang lead Viagra copies market
The polarization among local drugmakers is intensifying in the erectile dys...
by So Jae-hyeon
|
2018-01-22 14:44
라인
LG Chem wins sales approval for LBEC0101 in Japan
LG Chem said Friday that it has received sales approval from the Japanese M...
by Lee Han-soo
|
2018-01-22 11:59
라인
Antihypertensive, antiarteriosclerotic drugs surged last year
Prescription sales of antihypertensive drugs and antiarteriosclerotic treat...
by Nam Doo-hyun
|
2018-01-22 11:35
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top